Moderna
MRNA
#276
Rank
โ‚น8.265 T
Marketcap
โ‚น20,702
Share price
-7.82%
Change (1 day)
804.45%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -โ‚น281.93 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.21 Billion. In 2025 the company made an earning of -โ‚น261.9 Billion, an increase over its 2024 earnings that were of -โ‚น340.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น281.93 Billion7.65%
2025 -โ‚น261.9 Billion-23.03%
2024 -โ‚น340.25 Billion-8.22%
2023 -โ‚น370.73 Billion-140.65%
2022 โ‚น911.99 B-27.81%
2021 โ‚น1.263 T-1911.15%
2020 -โ‚น69.75 Billion44.7%
2019 -โ‚น48.21 Billion28.63%
2018 -โ‚น37.48 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.488 T-960.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.473 T-609.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น730.24 B-352.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.51 Billion-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น11.18 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น3.97 Billion-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น106.79 B-136.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚น15.15 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA